Johns Hopkins researchers helped secure full FDA approval to treat immunocompromised COVID-19 patients—paving the way to ...

A new antibody therapy effectively protects monkeys from severe H5N1 avian flu, offering hope for a universal flu vaccine and ...

Invivyd (IVVD) announced positive data from its ongoing Phase 1/2 clinical trial of VYD2311, Invivyd’s novel monoclonal antibody candidate ...

Recombinant antibodies are invented antibodies formed by using recombinant DNA technology. While traditional monoclonal ...

Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to ITM), announced ...

Vinny Cagnoni, a 7-year-old from Brighton, spent a year-and-a-half in the hospital after a respiratory infection he ...

With historical data showing migraine to be underdiagnosed and undertreated, new guidance from the American College of ...

A local couple, both firefighters, faced a personal crisis when their two-year-old son, Bentley, was diagnosed with ...

A Boston-area biopharmaceutical firm has submitted a biologics license application to the FDA for its investigational, fully ...

The stock options are subject to the terms and conditions of Xilio Therapeutics' 2022 Inducement Stock Incentive Plan, as ...

GBS begins with tingling or numbness in the feet and hands, followed by muscle weakness and difficulty moving joints.

Vaccines do not cause autism. You’ve almost certainly read that before — but often without a full explanation of how we know ...